Vivos Therapeutics (VVOS) Cash & Equivalents Growth (1y) (2020 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) Cash & Equivalents Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | 22.35% |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 1.35% |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | -33.43% |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | -46.58% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | 45.10% |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | -59.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -59.11% |
| Mar 31, 2026 | -9.91% |
| Dec 31, 2025 | -67.59% |
| Sep 30, 2025 | -50.88% |
| Jun 30, 2025 | -36.23% |
| Mar 31, 2025 | -10.30% |
| Dec 31, 2024 | 281.01% |
| Sep 30, 2024 | 531.10% |
| Jun 30, 2024 | 75.11% |
| Mar 31, 2024 | -62.94% |
| Dec 31, 2023 | -53.31% |
| Sep 30, 2023 | -85.12% |
| Jun 30, 2023 | -68.96% |
| Mar 31, 2023 | -60.48% |
| Dec 31, 2022 | -85.36% |
| Sep 30, 2022 | -76.45% |
| Jun 30, 2022 | -62.86% |
| Mar 31, 2022 | 26.82% |
| Dec 31, 2021 | 31.99% |
| Dec 31, 2020 | 3,778.96% |